 |
Penicillin Allergy and the Cephalosporins Evaluation
Objectives
Following this learning activity, the learner will be able to:
- State three reasons why the risk of allergic cross-reactivity between the penicillins and cephalosporins is much lower than the commonly cited 10 percent rate.
- Name two cephalosporins on the HealthPartners Formulary that should be prescribed cautiously for patients with a history of IgE-mediated penicillin allergy.
- Name three cephalosporins on the HealthPartners Formulary that may be prescribed safely for patients with a history of IgE-mediated penicillin allergy.
|
IME Bulletin Post Test (Penicillin Allergy and the Cephalosporins) (please check correct answers)
1. Most patients with a history of penicillin allergy are truly allergic to penicillin. |
|
2. During drug metabolism, the beta-lactam and thiazolidine/dihydrothiazine rings of the penicillins/cephalosporins form similar degradation products that increase the likelihood of allergic cross-reactions. |
|
3. The risk of allergic cross-reactions between the penicillins and cephalosporins is believed to depend primarily upon whether or not they have molecular side chain similarities. |
|
4. Cephalexin is a good antibiotic choice for patients who have experienced hives/urticaria while taking penicillin. |
|
Post Test Answer Key
Correct Answer: 1. False, 2. False, 3. True, 4. False
Evaluation
Please click on the response which most closely reflects your opinion. |
1. The objectives were met. |
|
2. The information was well organized, clearly presented, and easy to understand. |
|
3. The format was a good way to learn this information. |
|
4. The information will be relevant to my practice. |
|
5. Did you perceive any commercial bias in this presentation? |
|
|
The following fields are REQUIRED |
|
|
|
|
|
|
|
|
|
I certify that I have reviewed the information as designed for "Screening for Elevated Blood Lead Levels in High-Risk Children".
Unchecked "certify" or post-tests returned after the expiration date will not be processed. |
|